BIOMARIN PHARMACEUTICAL INC (BMRN) has 516 open-market insider trades by 26 insiders since 2005. Over the last six months insiders net sold $1.3M. The most active filer is Jean Jacques Bienaime, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jean Jacques Bienaime | Dir | — | 185 | $237.6M | 2024-05-20 |
| Henry J. Fuchs | Pres | — | 38 | $55.7M | 2024-09-13 |
| George Eric Davis | CLOVP | — | 54 | $47.6M | 2026-03-18 |
| Jeffrey Robert Ajer | CCOVP | — | 38 | $23.2M | 2024-05-02 |
| Daniel K. Spiegelman | CFOVP | — | 20 | $21.4M | 2019-04-30 |
| Robert Baffi | VP | — | 13 | $20.1M | 2020-03-20 |
| Brian Mueller | CFOVP | — | 25 | $11.7M | 2026-03-17 |
| Steve Aselage | EVPChief Business Officer | — | 16 | $8.8M | 2012-07-02 |
| V. Bryan Lawlis | Dir | — | 23 | $8.8M | 2023-05-23 |
| Elaine J. Heron | Dir | — | 8 | $8.5M | 2024-06-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Pharmaceutical Inc Biomarin | CLO & VP | Sell | $1.2M | 2026-09-02 |
| Gregory R. Friberg | VP | Sell | $177K | 2026-05-07 |
| Charles Greg Guyer | EVP & Chief Technical Officer | Sell | $997K | 2026-03-11 |
| Gregory R. Friberg | EVP & Chief R&D Officer | Sell | $382K | 2026-02-26 |
| George Eric Davis | CLO & VP | Sell | $1.6M | 2026-02-26 |
| Erin Burkhart | CAO | Sell | $212K |
Companies that share insiders with BMRN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-05-20 |
| Cristin Hubbard | EVP & Chief Commercial Officer | Sell | $18K | 2025-05-02 |
| Erin Burkhart | CAO | Sell | $185K | 2025-03-19 |
| Charles Greg Guyer | CTO & VP | Sell | $1.0M | 2025-03-06 |
| Erin Burkhart | CAO | Sell | $184K | 2025-02-24 |
| Charles Greg Guyer | CTO & VP | Sell | $701K | 2024-11-12 |
| Erin Burkhart | CAO | Sell | $64K | 2024-08-13 |
| Brian Mueller | CFO & VP | Sell | $376K | 2024-05-30 |
| George Eric Davis | CLO & VP | Sell | $6.1M | 2024-05-28 |
| Jean Jacques Bienaime | Director | Sell | $3.3M | 2024-05-09 |